Motzer and colleagues present updated results from a multicenter, phase III trial of sunitinib versus interferon-α as first-line treatment for patients with metastatic renal-cell carcinoma.

Present interferon-based therapy for chronic hepatitis C is limited by both efficacy and tolerability. Telaprevir and boceprevir are the first two direct-acting antiviral drugs (DAAs) that inhibit ...

In adults with chronic hepatitis B infection receiving viral suppression therapy, coupling an investigational small ...

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...

treatment-experienced (17) Arm 1: ABT-450/r (250/100 mg) + ABT-333 + RBV × 12 weeks Arm 2: ABT-450/r(150/100 mg) + ABT-333 + RBV × 12 weeks Arm 3: ABT-450/r(150/100 mg) + ABT-333 + RBV × 12 ...

“While 48 weeks of interferon can be used as a standard of care treatment for HBV patients, historically less than 10% of patients experience a functional cure. Here, with the combination of ...

The first patient received the treatment at Hull Royal Infirmary on Tuesday afternoon. It involves inhaling a protein called interferon beta which the body produces when it gets a viral infection.

"While 48 weeks of interferon can be used as a standard of care treatment for HBV patients, historically less than 10% of patients experience a functional cure. Here, with the combination of imdusiran ...

The following is a summary of “Type I interferon biomarker in idiopathic inflammatory myopathies: associations of Siglec-1 ...